Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001209191-23-006198

Options or other derivatives

  • Chief Medical Officer acquired 169,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Multani Pratik S Chief Medical Officer 2023-02-01 Grant or award · Stock Option (right to buy) +145,000 145,000 D
Multani Pratik S Chief Medical Officer 2023-02-01 Grant or award · Restricted Stock Unit +24,000 24,000 D
Loading xslF345X03/doc4.xml…